Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER (Q28186417)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: August 2005)

Language	Label	Description	Also known as
English	Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER	scientific article (publication date: August 2005)

Statements

scholarly article

0 references

Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER (English)

0 references

0 references

0 references

1

object named as

John G F Cleland

0 references

author name string

Alison P Coletta

2

0 references

Nick Freemantle

3

0 references

Periaswamy Velavan

4

0 references

Lwin Tin

5

0 references

Andrew L Clark

6

0 references

language of work or name

0 references

publication date

August 2005

0 references

European Journal of Heart Failure

0 references

7

0 references

5

0 references

931-6

0 references

Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Baseline characteristics of patients recruited into the CARE-HF study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Is there any hope for vitamin E?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

The relationship between cholesterol and survival in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Statin therapy is associated with lower mortality among patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.002

21 January 2018

Identifiers

10.1016/J.EJHEART.2005.04.002

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28186417&oldid=2116367871"